NMRA
Price
$0.84
Change
-$0.06 (-6.67%)
Updated
Jun 13 closing price
Capitalization
136.6M
58 days until earnings call
Z
Price
$70.37
Change
-$1.40 (-1.95%)
Updated
Jun 13 closing price
Capitalization
11.21B
46 days until earnings call
Interact to see
Advertisement

NMRA vs Z

Header iconNMRA vs Z Comparison
Open Charts NMRA vs ZBanner chart's image
Neumora Therapeutics
Price$0.84
Change-$0.06 (-6.67%)
Volume$592.11K
Capitalization136.6M
Zillow Group
Price$70.37
Change-$1.40 (-1.95%)
Volume$1.71M
Capitalization11.21B
NMRA vs Z Comparison Chart
Loading...
NMRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NMRA vs. Z commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NMRA is a Hold and Z is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 15, 2025
Stock price -- (NMRA: $0.84 vs. Z: $70.37)
Brand notoriety: NMRA: Not notable vs. Z: Notable
NMRA represents the Biotechnology, while Z is part of the Internet Software/Services industry
Current volume relative to the 65-day Moving Average: NMRA: 64% vs. Z: 74%
Market capitalization -- NMRA: $136.6M vs. Z: $11.21B
NMRA [@Biotechnology] is valued at $136.6M. Z’s [@Internet Software/Services] market capitalization is $11.21B. The market cap for tickers in the [@Biotechnology] industry ranges from $355.9B to $0. The market cap for tickers in the [@Internet Software/Services] industry ranges from $1.94T to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B. The average market capitalization across the [@Internet Software/Services] industry is $69.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NMRA’s FA Score shows that 1 FA rating(s) are green whileZ’s FA Score has 0 green FA rating(s).

  • NMRA’s FA Score: 1 green, 4 red.
  • Z’s FA Score: 0 green, 5 red.
According to our system of comparison, NMRA is a better buy in the long-term than Z.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NMRA’s TA Score shows that 5 TA indicator(s) are bullish while Z’s TA Score has 7 bullish TA indicator(s).

  • NMRA’s TA Score: 5 bullish, 4 bearish.
  • Z’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, Z is a better buy in the short-term than NMRA.

Price Growth

NMRA (@Biotechnology) experienced а -17.21% price change this week, while Z (@Internet Software/Services) price change was +0.11% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.75%. For the same industry, the average monthly price growth was +12.94%, and the average quarterly price growth was +4.02%.

The average weekly price growth across all stocks in the @Internet Software/Services industry was -1.25%. For the same industry, the average monthly price growth was +0.23%, and the average quarterly price growth was +9.96%.

Reported Earning Dates

NMRA is expected to report earnings on Aug 12, 2025.

Z is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (-0.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Internet Software/Services (-1.25% weekly)

Companies in this industry typically license software on a subscription basis and it is centrally hosted. Such products usually go by the names web-based software, on-demand software and hosted software. Cloud computing has emerged as a major force in this space, making it possible to save files to a remote database (without requiring them to be saved on local storage device); as long as a device has access to the web, it can access the data and the software programs to run it. This has in many cases facilitated cost efficiency, speed and security of data for businesses and consumers. Alphabet Inc., Facebook, Inc. and Yahoo! Inc. are some well-known names in the internet software/services industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
Z($11.2B) has a higher market cap than NMRA($137M). Z YTD gains are higher at: -4.970 vs. NMRA (-92.033). Z has higher annual earnings (EBITDA): 104M vs. NMRA (-262.83M). Z has more cash in the bank: 2.81B vs. NMRA (308M). NMRA has less debt than Z: NMRA (1.85M) vs Z (1.83B). Z has higher revenues than NMRA: Z (1.95B) vs NMRA (0).
NMRAZNMRA / Z
Capitalization137M11.2B1%
EBITDA-262.83M104M-253%
Gain YTD-92.033-4.9701,852%
P/E RatioN/A129.87-
Revenue01.95B-
Total Cash308M2.81B11%
Total Debt1.85M1.83B0%
FUNDAMENTALS RATINGS
Z: Fundamental Ratings
Z
OUTLOOK RATING
1..100
26
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
PROFIT vs RISK RATING
1..100
86
SMR RATING
1..100
90
PRICE GROWTH RATING
1..100
50
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NMRAZ
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
77%
Momentum
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
76%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 6 days ago
86%
Bullish Trend 11 days ago
79%
Declines
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 24 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
76%
Aroon
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
NMRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JEPRX13.91-0.10
-0.71%
JPMorgan Equity Premium Income R6
NSFGX11.60-0.10
-0.85%
Natixis Target Retirement 2035 N
CSVFX21.46-0.33
-1.51%
Columbia International Div Inc Inst
MSCGX10.75-0.17
-1.56%
Mercer US Small/Mid Cap Equity Y3
LCMGX18.76-0.36
-1.88%
Lord Abbett Micro Cap Growth C

NMRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, NMRA has been loosely correlated with NGNE. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if NMRA jumps, then NGNE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NMRA
1D Price
Change %
NMRA100%
-5.94%
NGNE - NMRA
38%
Loosely correlated
-3.14%
ABOS - NMRA
37%
Loosely correlated
-6.14%
AURA - NMRA
36%
Loosely correlated
-3.75%
SNDX - NMRA
35%
Loosely correlated
-3.94%
INZY - NMRA
34%
Loosely correlated
+0.25%
More

Z and

Correlation & Price change

A.I.dvisor indicates that over the last year, Z has been closely correlated with ZG. These tickers have moved in lockstep 99% of the time. This A.I.-generated data suggests there is a high statistical probability that if Z jumps, then ZG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To Z
1D Price
Change %
Z100%
-1.95%
ZG - Z
99%
Closely correlated
-2.21%
CARG - Z
51%
Loosely correlated
-4.71%
SNAP - Z
44%
Loosely correlated
-4.34%
META - Z
40%
Loosely correlated
-1.51%
SMWB - Z
40%
Loosely correlated
-6.27%
More